Loading ...

doxorubicin liquid crystalline nanoparticles

Based on

1 Articles
2014 Most recent source

Composition

1

3,7,11,15-tetramethylhexadecane-1,2,3-triol

3,7,11,15-tetramethylhexadecane-1,2,3-triol phytantriol PYT
Type Single Compound
Formula C20H42O3
Role core
2

poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) triblock copolymer

Pluronic F-127
Type Polymer
Formula
Role layer
3

doxorubicin

adriblastin adriamycin DOX DXR
Type Single Compound
Formula C27H29NO11
Role loaded material

Properties

Applications

Characterization

Biological effects

Biological system Test details Nanomaterial Variant Source
female Sprague-Dawley rat

More information/entries available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • 3,7,11,15-tetramethylhexadecane-1,2,3-triol
  • doxorubicin
  1. gnIoIc4pqtO3RmYZu0pATjMIeCQT9IN
Product

doxorubicin liquid crystalline nanoparticles

Hydrodynamic diameter: 282.76 - 296.24 nm

Medium/Support: none

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial